Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Apr-24 9:12 PM View:  | BioSante Pharmaceuticals, I... (ANIP) | 10-Apr-24 | Payment of Exercise | 4,534 | $66.96 | $303,597.00 | (3%) 171.5K to 166.97K | |
| 25-Mar-24 4:17 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-24 | Payment of Exercise | 6,210 | $69.58 | $432,092.00 | (3%) 177.71K to 171.5K | |
| 11-Mar-24 6:39 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 11-Mar-24 | Sale | 7,787 | $65.55 | $510,438.00 | (4%) 185.5K to 177.71K | |
| 11-Mar-24 6:39 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Mar-24 | Payment of Exercise | 4,216 | $66.71 | $281,249.00 | (2%) 189.72K to 185.5K | |
| 01-Mar-24 4:55 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 29-Feb-24 | Payment of Exercise | 1,914 | $67.67 | $129,520.00 | (< 1%) 191.63K to 189.72K | |
| 16-Feb-24 4:26 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 14-Feb-24 | Grant | 35,790 | -- | -- | 23% 155.84K to 191.63K | |
| 16-Aug-23 4:24 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 14-Aug-23 | Private Sale | 17,639 | $61.37 | $1,082,510.00 | (10%) 173.48K to 155.84K | |
| 12-Apr-23 4:43 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 10-Apr-23 | Payment of Exercise | 4,534 | $38.50 | $174,559.00 | (3%) 178.01K to 173.48K | (13%) |
| 30-Mar-23 8:00 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Mar-23 | Payment of Exercise | 1,420 | $38.62 | $54,840.40 | (1%) 138.91K to 137.49K | (13%) |
| 27-Mar-23 8:00 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-23 | Payment of Exercise | 4,224 | $37.82 | $159,752.00 | (3%) 143.13K to 138.91K | |
| 09-Mar-23 6:45 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Mar-23 | Payment of Exercise | 3,503 | $44.23 | $154,938.00 | (2%) 146.63K to 143.13K | 2% |
| 06-Apr-23 8:00 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Feb-23 | Grant | 40,526 | -- | -- | 29% 137.49K to 178.01K | |
| 29-Apr-22 6:34 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 27-Apr-22 | Grant | 11,291 | -- | -- | 8% 135.34K to 146.63K | |
| 12-Apr-22 5:11 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 10-Apr-22 | Payment of Exercise | 4,534 | $29.91 | $135,612.00 | (3%) 139.88K to 135.34K | |
| 08-Apr-22 5:37 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Apr-22 | Payment of Exercise | 912 | $29.69 | $27,077.30 | (< 1%) 140.79K to 139.88K | |
| 30-Mar-22 4:10 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Mar-22 | Payment of Exercise | 1,420 | $28.17 | $40,001.40 | (< 1%) 142.21K to 140.79K | |
| 28-Mar-22 8:48 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 24-Mar-22 | Grant | 33,875 | -- | -- | 31% 108.33K to 142.21K | |
| 25-Mar-22 8:53 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-22 | Payment of Exercise | 4,167 | $27.03 | $112,634.00 | (4%) 112.5K to 108.33K | |
| 13-Apr-21 5:25 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 12-Apr-21 | Payment of Exercise | 3,042 | $31.86 | $96,918.10 | (3%) 115.54K to 112.5K | (2%) |
| 07-Apr-21 8:19 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Apr-21 | Payment of Exercise | 612 | $33.69 | $20,618.30 | (< 1%) 116.15K to 115.54K | (< 1%) |
| 31-Mar-21 8:56 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 31-Mar-21 | Payment of Exercise | 508 | $36.14 | $18,359.10 | (< 1%) 116.66K to 116.15K | |
| 31-Mar-21 8:56 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 29-Mar-21 | Payment of Exercise | 953 | $32.68 | $31,144.00 | (< 1%) 117.61K to 116.66K | (< 1%) |
| 25-Mar-21 4:44 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-21 | Grant | 54,470 | -- | -- | 86% 63.15K to 117.61K | |
| 14-Apr-20 4:32 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 10-Apr-20 | Grant | 39,767 | -- | -- | 170% 23.38K to 63.15K | |
| 08-Apr-20 5:53 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Apr-20 | Payment of Exercise | 612 | $43.22 | $26,450.60 | (3%) 23.99K to 23.38K | |
| 31-Mar-20 9:39 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 31-Mar-20 | Payment of Exercise | 507 | $40.74 | $20,655.20 | (2%) 24.5K to 23.99K | |
| 31-Mar-20 9:39 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Mar-20 | Payment of Exercise | 953 | $37.76 | $35,985.30 | (4%) 25.45K to 24.5K | |
| 09-Apr-19 4:42 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Apr-19 | Payment of Exercise | 612 | $70.50 | $43,146.00 | (2%) 26.06K to 25.45K | (< 1%) |
| 02-Apr-19 4:42 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 31-Mar-19 | Payment of Exercise | 507 | $70.54 | $35,763.80 | (2%) 26.57K to 26.06K | (< 1%) |
| 01-Apr-19 4:01 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Mar-19 | Grant | 12,451 | -- | -- | 88% 14.12K to 26.57K | |
| 10-Apr-18 5:25 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Apr-18 | Grant | 8,000 | -- | -- | 131% 6.12K to 14.12K | |
| 03-Apr-18 5:17 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 31-Mar-18 | Payment of Exercise | 507 | $58.22 | $29,517.50 | (8%) 6.63K to 6.12K | (21%) |
| 04-Apr-17 6:01 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 31-Mar-17 | Grant | 6,625 | -- | -- | 100% 0 to 6.63K |